Aging and senescence: Key players in brain tumor progression and drug resistance
Drug Resistance Updates · 2025-07 · 81 · 101228
DOI: 10.1016/j.drup.2025.101228 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025-07. Verfasst von Chao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China. Electronic address: czhangsinap@163.com. Hauptthemen laut MEDLINE: Brain Neoplasms, Drug Resistance, Neoplasm, Aging, Glioblastoma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 200 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Traditional Chinese Medicine Bureau of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aging plays a critical role in the development, progression, and therapeutic challenges associated with brain tumors, particularly glioblastomas (GBM). As the population ages, the incidence of brain tumors, including GBM, increases, with aging emerging as a significant prognostic factor influencing survival outcomes. This review examines the molecular mechanisms linking aging and brain tumor progression, with a specific focus on glioblastomas. We explore how age-related genetic mutations, alterations in cellular pathways, and changes in the tumor microenvironment (TME) contribute to tumorigenesis and treatment resistance. Furthermore, we highlight the impact of key signaling pathways, such as the PI3K/AKT/mTOR, p53, and EGFR/PTEN, which are frequently dysregulated in both aging and brain tumors. Despite the growing recognition of aging as a critical factor in brain tumor biology, therapeutic strategies for elderly patients remain poorly defined, often due to underrepresentation in clinical trials and the complex interplay of comorbidities and treatment side effects. The review also discusses emerging therapeutic approaches, including targeted therapies and immunotherapies, which offer promise for improving treatment outcomes by addressing age-related molecular changes. Finally, we emphasize the importance of personalized treatment strategies and the need for further research to better understand the biological mechanisms underlying the aging-brain tumor relationship, ultimately aiming to enhance clinical management and patient quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China. Electronic address: czhangsinap@163.com.
- Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India. Electronic address: neha.bhardwaj_sch@jamiahamdard.ac.in.
- Department of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China. Electronic address: zhangjq63@mail2.sysu.edu.cn.
- Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India. Electronic address: prashantdhaka@jamiahamdard.ac.in.
- Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China. Electronic address: lixiaodie_1@163.com.
- Department of Biotechnology, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur 273009, India. Electronic address: saradmishra5@gmail.com.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Traditional Chinese Medicine Bureau of Guangdong Province
- National Natural Science Foundation of China
- Ningxia Medical University
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Zhang, C., Neha, Zhang, J., Dhaha, P., Li, X., Mishra, S. K., Fleishman, J., Parvez, S., Jha, S. K., & Huang, M. (2025). Aging and senescence: Key players in brain tumor progression and drug resistance. Drug Resistance Updates, 81, 101228. https://doi.org/10.1016/j.drup.2025.101228
Vancouver
Zhang C, Neha, Zhang J, Dhaha P, Li X, Mishra SK, et al. Aging and senescence: Key players in brain tumor progression and drug resistance. Drug Resistance Updates. 2025;81:101228. doi:10.1016/j.drup.2025.101228
BibTeX
@article{Zhang2025,
author = {Zhang, Chao and Neha and Zhang, Jiaqi and Dhaha, Prashant and Li, Xiaodie and Mishra, Sarad Kumar and Fleishman, Joshua and Parvez, Suhel and Jha, Saurabh Kumar and Huang, Min},
title = {Aging and senescence: Key players in brain tumor progression and drug resistance},
journal = {Drug Resistance Updates},
year = {2025},
volume = {81},
pages = {101228},
doi = {10.1016/j.drup.2025.101228}
}
EUVIMED